Common use of Genzyme Technology Clause in Contracts

Genzyme Technology. Subject to the provisions of any In-License, Genzyme shall have the sole and exclusive right to initiate an infringement or other appropriate suit (an “Infringement Action”) anywhere in the world against any Third Party as to any infringement, or suspected infringement of, any Patent Rights, or as to any use or suspected use without proper authorization of any Know-How, comprising Genzyme Patent Rights, Genzyme Know-How, Genzyme Collaboration IP or Genzyme Manufacturing IP.

Appears in 2 contracts

Sources: Global License Agreement (Alnylam Pharmaceuticals, Inc.), Master Collaboration Agreement (Alnylam Pharmaceuticals, Inc.)